RNA antagonist compounds for the inhibition of Apo-Bl00 expression

Details for Australian Patent Application No. 2006291836 (hide)

Owner Santaris Pharma A/S

Inventors Hansen, Bo; Hansen, Henrik Frydenlund; Rosenbohm, Christoph; Straarup, Ellen Marie; Westergaard, Majken

Agent FB Rice

Pub. Number AU-B-2006291836

PCT Pub. Number WO2007/031081

Priority PA 2006 00598 27.04.06 DK; 60/796,211 27.04.06 US; 60/718,018 15.09.05 US

Filing date 1 September 2006

Wipo publication date 22 March 2007

Acceptance publication date 23 February 2012

International Classifications

C07K 14/77 (2006.01) Peptides having more than 20 amino acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/031081 Priority application(s): WO2007/031081

23 February 2012 Application Accepted

  Published as AU-B-2006291836

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006291863-Dengue virus capsid protein which induces a protective response and pharmaceutical composition

2006291835-A method for quantification of allergens